Net Income

The tire retailer returns to the prestigious list, highlighting how its people-first strategy is a winning formula in a challenging retail market.

The American Water Charitable Foundation launches its 2026 grant program, funding vital community projects for clean water, conservation, and education.

With dentist burnout at crisis levels, one veteran practitioner offers a $6M blueprint to help owners escape the grind and reclaim their lives.

A new giant enters the ring. Akralos Animal Nutrition, an ADM-Alltech venture, launches with 40+ mills, aiming to reshape the North American market.

Kong Inc. unveils a new architectural vision to unify APIs, models, and agents, aiming to solve the enterprise challenge of scaling AI safely and efficiently.

Beyond M&A, ACROBiosystems' bioSeedin summit redefines growth, connecting global capital with biotech innovation in a new era of strategic partnerships.

As AI systems deny healthcare claims at alarming rates, experts argue that human oversight is the only safeguard for both patients and payors.

Japanese insurer Meiji Yasuda finalizes its acquisition of a top U.S. life and pension player, signaling a major strategic push into the American market.

Devonian appoints veteran CFO Dennis Turpin and corrects stock options, signaling a strategic shift as it aims to overcome financial hurdles and advance its pipeline.

With home health aide costs nearing $78,000 annually, families face a financial maze. Learn key strategies for creating a realistic budget for senior care.

AI identity firm Trust Stamp unveils a bold 2026 plan, targeting acquisitions, African markets, and the stablecoin economy to fuel its global expansion.

A new campaign from ZOLL LifeVest and the AHA targets the deadly disparity in women's cardiac care, blending advocacy with life-saving wearable technology.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

Shanghai's AI EdTech innovator Jinxin faces a potential Nasdaq delisting after its stock plummets, putting its high-tech vision against market reality.

Smashing its target, Hamilton Lane's new fund highlights intense investor appetite for assets powering AI, logistics, and the energy transition.

A cancer researcher's 2,115% gain and a Hong Kong trader's 1,499% two-year run redefine market outperformance in the 2025 Investing Championship.

A new report reveals banks are past debating AI, focusing instead on responsible deployment for fraud and efficiency, signaling a pragmatic future.

A new FAIR Health report finds 57.5% of commercially insured Americans have a chronic condition, with costs nearly doubling for patients with just one.

AI robotics firm Realbotix sells its legacy crypto domain portfolio for $2.245M to an unexpected buyer: the new Bed Bath & Beyond, signaling a major Web3 push.